author-photo

N. Voitko

3

Papers

5

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta ® in the prophylactic treatment of chemotherapy-induced neutropenia

2017 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-neulasta® in the prophylaxis of chemotherapy-induced neutropenia

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)